Abstract
To evaluate the feasibility of using magnetic iron oxide nanoparticle as wild PTEN gene carrier for transfection in vitro to reverse cisplatin-resistance of A549/CDDP cells, A549/CDDP cells were transfected with the wild PTEN gene expression plasmid (pGFP-PTEN) by magnetic iron nanoparticle and lipo2000. The transfection efficiency was detected by fluorescence microscope and flow cytometer. The expression levels of PTEN mRNA and protein were detected by reverse transcription polymerase chain reaction (RT-PCR) and immunocytochemistry analysis. The effect of PTEN transfection on cell cycle enhances the sensitivity of A549/CDDP to cisplatin and nanoparticle-mediated transfection has a higher efficiency than that of the liposome-mediated group. The apoptosis level was up-regulated in PTEN transfection group. The magnetic iron oxide nanoparticle could be used as one of the ideal gene carriers for PTEN gene delivery in vitro. PTEN can be an effective target for reversing cisplatin-resistance in lung cancer.
Similar content being viewed by others
References
STECK P A, PERSHOUSE M A, JASSER S A, YUNG W K, LIN H, LIGON A H, LANGFORD L A, BAUMGARD M L, HATTIER T, DAVIS T, FRYE C, HU R, SWEDLUND B, TENG D H, TAVTIGIAN S V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers [J]. Nat Genet, 1997, 15(4): 356–362.
PLANCHON S M, WAITE K A, ENG C. The nuclear affairs of PTEN [J]. J Cell Sci, 2008, 121(Pt 3): 249–253.
HO C M, LIN M C, HUANG S H, HUANG C J, LAI H C, CHIEN T Y, CHANG S F. PTEN promoter methylation and LOH of 10q22–23 locus in PTEN expression of ovarian clear cell adenocarcinomas [J]. Gynecol Oncol, 2009, 112(2): 307–313.
IWANAGA K, YANG Y, RASO M G, MA L, HANNA A E, THILAGANATHAN N, MOGHADDAM S, EVANS C M, LI H, CAI W W, SATO M, MINNA J D, WU H, CREIGHTON C J, DEMAYO F J, WISTUBA I I, KURIE J M. Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer [J]. Cancer Res, 2008, 68(4): 1119–1127.
LIM W T, ZHANG W H, MILLER C R, WATTERS J W, GAO F, VISWANATHAN A, GOVINDAN R, MCLEOD H L. PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer [J]. Oncol Rep, 2007, 17(4): 853–857.
HOSOYA Y, GEMMA A, SEIKE M, KURIMOTO F, UEMATSU K, HIBINO S, YOSHIMURA A, SHIBUYA M, KUDOH S. Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis [J]. Lung Cancer, 1999, 25(2): 87–93.
INAMURA K, TOGASHI Y, NOMURA K, NINOMIYA H, HIRAMATSU M, OKUI M, SATOH Y, OKUMURA S, NAKAGAWA K, TSUCHIYA E, ISHIKAWA Y. Up-regulation of PTEN at the transcriptional level is an adverse prognostic factor in female lung adenocarcinomas [J]. Lung Cancer, 2007, 57(2): 201–206.
PERRONE F, LAMPIS A, ORSENIGO M, DI BARTOLOMEO M, GEVORGYAN A, LOSA M, FRATTINI M, RIVA C, ANDREOLA S, BAJETTA E, BERTARIO L, LEO E, PIEROTTI M A, PILOTTI S. PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients [J]. Ann Oncol, 2009, 20(1): 84–90.
TANAKA M, KOUL D, DAVIES M A, LIEBERT M, STECK P A, GROSSMAN H B. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells [J]. Oncogene, 2000, 19(47): 5406–5412.
ZHOU M, GU L, FINDLEY H W, JIANG R, WOODS W G. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells [J]. Cancer Res, 2003, 63(19): 6357–6362.
WENG L, BROWN J, ENG C. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways [J]. Hum Mol Genet, 2001, 10(3): 237–42.
XIN J, YANG-DE Z, JI-WEI W, LI-HUA Z, PU Y, XU Z, YU H, LI Y. Preparation and characterization of fluorimetric folate-coupled chitosan nano-carrier [J]. Journal of Central South University: Science and Technology, 2010, 41(1): 161–165. (in Chinese)
DATILES M J, JOHNSON E A, MCCARTY R E. Inhibition of the ATPase activity of the catalytic portion of ATP synthases by cationic amphiphiles [J]. Biochim Biophys Acta, 2008, 1777(4): 362–368.
de MARTIMPREY H, VAUTHIER C, MALVY C, COUVREUR P. Polymer nanocarriers for the delivery of small fragments of nucleic acids: Oligonucleotides and siRNA [J]. Eur J Pharm Biopharm, 2009, 71(3): 490–504.
WU H, CAO Y, WENG D, XING H, SONG X, ZHOU J, XU G, LU Y, WANG S, MA D. Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms [J]. Cancer Lett, 2008, 271(2): 260–271.
STEELMAN L S, NAVOLANIC P M, SOKOLOSKY M L, TAYLOR J R, LEHMANN B D, CHAPPELL W H, ABRAMS S L, WONG E W, STADELMAN K M, TERRIAN D M, LESLIE N R, MARTELLI A M, STIVALA F, LIBRA M, FRANKLIN R A, MCCUBREY J A. Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors [J]. Oncogene, 2008, 27(29): 4086–4095.
WU H, WANG S, WENG D, XING H, SONG X, ZHU T, XIA X, WENG Y, XU G, MENG L, ZHOU J, MA D. Reversal of the malignant phenotype of ovarian cancer A2780 cells through transfection with wild-type PTEN gene [J]. Cancer Lett, 2008, 271(2): 205–214.
WANG S, CHENG Z, YANG X, DENG K, CAO Y, CHEN H, PAN L. Effect of wild type PTEN gene on proliferation and invasion of multiple myeloma [J]. Int J Hematol, 2010, 92(1): 83–94.
LI D M, SUN H. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells [J]. Proc Natl Acad Sci USA, 1998, 95(26): 15406–1511.
WENG L P, SMITH W M, DAHIA P L, ZIEBOLD U, GIL E, LEES J A, ENG C. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death [J]. Cancer Res, 1999, 59(22): 5808–5814.
BRUNI P, BOCCIA A, BALDASSARRE G, TRAPASSO F, SANTORO M, CHIAPPETTA G, FUSCO A, VIGLIETTO G. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: Evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1 [J]. Oncogene, 2000. 19(28): 3146–3155.
KNOBLOCH J, SCHMITZ I, GOTZ K, SCHULZE-OSTHOFF K, RUTHER U. Thalidomide induces limb anomalies by PTEN stabilization, Akt suppression, and stimulation of caspase-dependent cell death [J]. Mol Cell Biol, 2008, 28(2): 529–538.
THOMAS M, KLIBANOV A M. Non-viral gene therapy: Polycation-mediated DNA delivery [J]. Appl Microbiol Biotechnol, 2003, 62(1): 27–34.
SORSCHER S M. Metastatic acinar cell carcinoma of the pancreas responding to gemcitabine, 5-fluorouracil and leucovorin therapy: A case report [J]. Eur J Cancer Care (Engl), 2009, 18(3): 318–319.
KROTZ F, de WIT C, SOHN H Y, ZAHLER S, GLOE T, POHL U, PLANK C. Magnetofection-A highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo [J]. Mol Ther, 2003, 7(5): 700–710.
Author information
Authors and Affiliations
Corresponding author
Additional information
Foundation item: Project(07JJ3055) supported by the Natural Science Foundation of Hunan Province, China
Rights and permissions
About this article
Cite this article
Min, Lf., He, Ll., Chen, Q. et al. Magnetic iron oxide nanoparticles carrying PTEN gene to reverse cisplatin-resistance of A549/CDDP cell lines. J. Cent. South Univ. Technol. 19, 331–339 (2012). https://doi.org/10.1007/s11771-012-1009-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11771-012-1009-2